HGH / Somatropin

GH Axis / Anabolic

Growth, lean-mass and tissue-turnover effects

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Protein hormone
Primary mechanism: GH receptor activation
Primary market use: Growth hormone deficiency

Pharmacology

Molecular weight (Da): ~22,100
Oral bioavailability: N/A
Half-life: ~2-3 h
Route tags: Route-dependent / verify
Evidence level: Approved
Clinical status: Approved
Value-for-money score: 5 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Durable if actual growth/tissue remodeling occurs

Sources

https://www.fda.gov/drugs